EGFR and neoplasm: These findings underscore the essential role of 6PGD phosphorylation in EGFR-promoted tumor growth and radiation resistance, suggesting therapeutic potential to dampen brain tumor development and sensitize glioma to radiotherapy through inhibiting 6PGD phosphorylation.